secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIORA THERAPEUTICS, INC. (—)
CIK:        0001580063
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001193125-23-163496
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biora Therapeutics cures Nasdaq listing deficiency; stock to remain on Global Market
--------------------------------------------------------------------------------

- Nasdaq confirmed Biora cured noncompliance with $50M total assets and $50M total revenue continued listing requirement.
- The matter is closed; common stock remains listed on The Nasdaq Global Market.
- Letter received June 8, 2023; no further action needed from Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580063/000119312523163496/0001193125-23-163496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580063/000119312523163496/d574823d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-163496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer